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ABSTRACT 
To maintain genomic integrity cells have to respond properly to a variety of exogenous 
and endogenous factors that produce genome injuries and interfere with DNA 
replication. DNA integrity checkpoints coordinate this response by slowing cell cycle 
progression to provide time for the cell to repair the damage, stabilizing replication 
forks and stimulating DNA repair to restore the original DNA sequence and structure. 
In addition, there are also mechanisms of damage tolerance, such as translesion 
synthesis (TLS), which are important for survival after DNA damage. TLS allows 
replication to continue without removing the damage, but results in a higher frequency 
of mutagenesis. Here, we investigate the functional contribution of the Dot1 histone 
methyltransferase and the Rad53 checkpoint kinase to TLS regulation in 
Saccharomyces cerevisiae. We demonstrate that the Dot1-dependent status of H3K79 
methylation modulates the resistance to the alkylating agent MMS, which depends on 
PCNA ubiquitylation at lysine 164. Strikingkly, either the absence of DOT1, which 
prevents full activation of Rad53, or the expression of an HA-tagged version of RAD53, 
which produces low amounts of the kinase, confer increased MMS resistance. However, 
the dot1 rad53-HA double mutant is hypersensitive to MMS and shows barely 
detectable amounts of activated kinase. Furthermore, moderate overexpression of 
RAD53 partially suppresses the MMS resistance of dot1. In addition, we show that 
MMS-treated dot1 and rad53-HA cells display increased number of chromosome-
associated Rev1 foci. We propose that threshold levels of Rad53 activity exquisitely 
modulate the tolerance to alkylating damage at least by controlling the abundance of the 
key TLS factor Rev1 bound to chromatin.  
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1. Introduction 
 The genome is constantly hit by multiple sources of exogenous and endogenous 
damage that compromise its integrity. Eukaryotic cells respond to the presence of 
genome injuries by activating surveillance mechanisms referred to as DNA damage or 
DNA integrity checkpoints. The inability to properly react to DNA damage results in 
genome instability, which in mammalian systems is linked to tumor development [1-3]. 
 In Saccharomyces cerevisiae, DNA damage is initially detected by the 
Mec1/Ddc2 (ATR/ATRIP) and the clamp-like Ddc1-Rad17-Mec3 (‘9-1-1’) complexes. 
These checkpoint sensors are independently recruited to the sites of damage and trigger 
the activation of the Rad53 and Chk1 effector kinases in a process mediated by the 
Rad9 and Mrc1 adaptors. In turn, the effector kinases act on the corresponding targets to 
promote the different cellular responses to cope with the DNA damage, including cell 
cycle arrest, stabilization of replication forks and activation of DNA repair [4]. 
 Eukaryotic cells are equipped with a broad range of specialized DNA repair 
pathways to confront and eliminate the great variety of genomic insults of different 
nature that can arise during different cell cycle stages, but lesions occurring during S 
phase that can stall replication forks are particularly threatening [5,6]. Thus, in addition 
to the repair pathways to remove the lesions, cells possess tolerance mechanisms, such 
as translesion synthesis (TLS) and template switching, that allow replication to continue 
despite the presence of DNA damage [7]. These tolerance pathways are critical for 
survival in the face of DNA damage. TLS is mediated by specialized polymerases that, 
in contrast to replicative polymerases, are able to insert nucleotides opposite damaged 
templates, although at the cost of increasing the mutagenesis rate. Therefore, this 
tolerance pathway must be tightly controlled. In yeast, TLS is performed by the Pol 
polymerase (encoded by the RAD30 gene), and by the Pol polymerase composed by 
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the Rev3 (catalytic) and Rev7 (regulatory) subunits [8]. In addition, the Rev1 protein 
also plays a critical role in TLS. Although Rev1 possesses deoxycytidyl transferase 
activity, its main TLS function is structural and does not rely on the catalytic activity 
[9,10]. In eukaryotes, DNA damage tolerance is exquisitely controlled by ubiquitylation 
of the DNA sliding clamp PCNA at the lysine 164 [11]. Thus, Rad6/Rad18-dependent 
monoubiquitylation of PCNA-K164 triggers TLS, whereas polyubiquitylation of 
PCNA-K164 through Ubc13/Mms2/Rad5 induces the template-switch error-free mode 
of damage bypass by sister-strand recombination [7,12-14]. 
 Genome injuries do not occur on the naked DNA, but rather in the context of the 
highly organized chromatin. Indeed, during the recent years significant advances have 
been made in understanding the contribution of chromatin modifications to several 
aspects of the DNA damage response, such as detection, signaling and repair of the 
damage [15-20]. However, little is known about how chromatin structure may impinge 
on DNA damage tolerance, although a recent report has described a role for the INO80 
remodeling complex in DNA damage tolerance through modulation of PCNA 
ubiquitylation [21]. Methylation of lysine 79 in histone H3 (hereafter H3K79-me) by 
the Dot1 methyltransferase is one of the various histone modifications involved in the 
cellular responses to DNA damage. Dot1 orchestrates several aspects of chromosome 
metabolism both in mitotic and meiotic cells, including transcriptional silencing [22-
25], activation of the meiotic recombination checkpoint and regulation of recombination 
partner choice in meiosis [26], repair of double-strand breaks by sister-chromatid 
recombination in mitotic cells [27], and repair of IR- and UV-induced lesions [28-31]. 
In addition, Dot1 participates in the DNA damage checkpoint in vegetative yeast cells 
being required for Rad9-mediated activation of the Rad53 effector kinase, at least 
during the G1-S cell cycle transitions [32,33]. Moreover, we have recently reported that 
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Dot1 negatively regulates the Pol/Rev1-dependent pathway of tolerance to alkylating 
DNA damage. Indeed, deletion of DOT1 results in increased Rev3-dependent 
mutagenesis [34]. Dot1 is conserved form yeast to human; importantly, altered function 
of human DOT1L is linked to leukemia development [35-39].  
 Here we investigate in more detail how Dot1 function contributes to the 
regulation of DNA damage tolerance. We find that Dot1 modulates the response to the 
alkylating agent MMS through its catalytic activity on H3K79. In fact, progressively 
reduced levels of H3K79 trimethylation result in gradually increased resistance to 
MMS. In addition, we examine the functional interaction between Dot1 and an HA-
tagged version of the Rad53 checkpoint kinase that also promotes increased MMS 
resistance and mutagenesis [40]. Our results indicate that there is a window of 
opportunity for TLS to act in the face of MMS lesions that is delineated by threshold 
levels of Rad53 activity. Moreover, we present evidence indicating that the contribution 
of Dot1 to DNA damage tolerance is exerted via Rad53 and controls the levels of Rev1 
protein associated with chromosomes. 
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2. Materials and methods 
 
 
2.1. Strains and plasmids 
Yeast strains and plasmids used in this work are listed in Table 1 and Table 2, 
respectively. REV1-13myc::HISMX6 and rad53-3HA::TRP1 tagging, as well as 
dot1::kanMX6 gene deletion, were performed using standard PCR-based approaches 
[41]. Plasmid pSS30 was used to generate dot1::URA3 [26]. Gene modifications were 
introduced either by direct transformation or by genetic crosses always in an isogenic 
background. To generate the strains carrying the dot1-G401A and dot1-G401V alleles at 
the genomic locus, the pRS306-based plasmids pFF003 and pTW043, kindly provided 
by Fred van Leeuwen (NKI, Netherlands) were cut with MluI and targeted to the DOT1 
promoter in dot1::kanMX6 strains lacking the whole DOT1 coding region. Plasmids 
pRS315-DOT1 and pFvL54, which contain DOT1 and dot1-G401V respectively, in the 
pRS315 low-copy vector were also provided by F. van Leeuwen [42]. Strains YP712, 
YP1175, YP1181 and YP1185 carry the zip1::LYS2 deletion. Zip1 is a meiosis-specific 
structural component of the yeast synaptonemal complex [43]; therefore, the presence 
or absence of the ZIP1 gene does not have any effect in vegetative haploid yeast. Strains 
harboring the hht1-K79A and pol30-K164R alleles were kindly provided by Mary Ann 
Osley (University of New Mexico) and Takashi Hishida (Osaka University), 
respectively. Functionality of the REV1-myc tagged gene was confirmed by the lack of 
MMS sensitivity. The high-copy plasmid pSS145 containing RAD53 was constructed by 
cloning the 3.6-kb EcoRI fragment from pCB583 (provided by the lab of M. Foiani, 
IFOM, Italy) into the 2 vector pRS426. 
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2.2. MMS sensitivity assays 
Exponentially growing cells were serially diluted in water and 5 l were spotted onto 
YPDA plates (YPD supplemented with 50 g/ml adenine) or YPDA plates containing 
MMS (Sigma) at various concentrations and incubated at 30ºC. MMS plates were 
always freshly made. When the strains to be analyzed contained plasmids, cells were 
grown on selective medium (SC) lacking the corresponding nutrient. Quantification of 
the MMS resistance was carried out by plating the same number of exponentially 
growing cells onto YPDA and MMS-containing plates. The MMS resistance was 
determined by counting the colonies growing on MMS plates relative to the YPDA. 
Colonies were counted using the colony counting tool of the Quantity One software 
(Bio-Rad). The quantification was always done at least in triplicate. To calculate the 
statistical significance of differences in MMS resistance in Figure 6C, a two-tailed 
unpaired Student t-test was performed using the GraphPad Prism version 4.0 software. 
 
2.3. Western blot analysis 
TCA cell extracts were prepared and analyzed essentially as described [34]. SDS-PAGE 
gels at 15%, 10% and 7.5% were used for detection of histone H3, Dot1 and Rad53, 
respectively. Antibodies that specifically recognize H3K79-me1 (ab2886), H3K79-me2 
(ab3594), H3K79-me3 (ab2621) and total histone H3 (ab1791) were from Abcam and 
were used at 1:1000 dilution for H3K79-me1 and 1:4000 dilution for the rest. The anti-
Rad53 (sc-6749; Santa Cruz Biotechnology) and anti-HA (12CA5; Roche) antibodies 
were used at 1:2000 dilution. The rabbit polyclonal anti-Dot1 antibody was a kind gift 
from R. Freire (HUC, Tenerife, Spain) and was used at 1:1000 dilution. HRP-
conjugated secondary antibodies were from Santa Cruz or GE Healthcare. The ECL or 
ECL-Plus reagents (GE Healthcare) were used for detection. For quantification of 
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H3K79 methylation levels, the chemiluminescence signal was captured with a 
ChemiDoc XRS (Bio-Rad) apparatus and analyzed with the Quantity One software. 
Only non-saturated bands in the linear range of detection were considered for 
quantification. 
 
2.4. Citology 
Immunofluorescence of nuclear spreads was performed essentially as described [44]. 
The anti-myc tag antibody (clone 4A6, 05-724; Millipore) was used at 1:500 dilution 
and the Alexa Fluor 594-conjugated anti-mouse secondary antibody (A11032; 
Molecular Probes) was used at 1:200 dilution. Images were captured using a Nikon 
Eclipse 90i fluorescence microscope equipped with an Orca-AG (Hamamatsu) CCD 
camera and a PlanApo VC 100X/1.4 objective. Images were processed and analyzed 
with the MetaMorph software (Molecular Devices). Quantification of chromosome-
associated Rev1 was performed by counting the number of Rev1 foci in the DAPI-
stained area delimited using the MetaMorph tools.  
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3. Results 
 
3.1. Dot1-dependent histone H3K79 methylation regulates tolerance to alkylating 
DNA damage 
 We have previously reported that the absence of Dot1 results in increased 
resistance to chronic MMS exposure as a consequence of enhanced TLS-mediated 
tolerance [34]. The only known biochemical function of Dot1 is the mono-, di-, and 
trimethylation of lysine 79 in histone H3 [25]. To determine whether regulation of 
MMS resistance by Dot1 relies on its methyltransferase activity, we analyzed a 
catalytically-inactive dot1-G401V mutant, in which the glycine at position 401 in the 
Dot1 active site has been substituted by a valine (Fig. 1A; [45]). Like dot1, the dot1-
G401V mutant completely lacked detectable H3K79 methyltransferase activity (Fig. 
1B) and also displayed enhanced MMS resistance relative to the isogenic wild-type 
strain (Figs. 1C and 2B), indicating that the catalytic activity of Dot1 is required for its 
function in MMS tolerance. The only known substrate of Dot1 is H3K79; therefore, to 
confirm that the MMS resistance of dot1 is due to the lack of H3K79 methylation, we 
analyzed an H3-K79A mutant, in which the lysine 79 targeted by Dot1 has been 
replaced by an alanine and cannot be methylated [46]. Like dot1, the H3-K79A allele 
conferred increased MMS resistance (Fig. 1D). 
 To investigate in more detail the regulation of DNA damage tolerance by 
H3K79 methylation, we examined MMS resistance in strains exhibiting gradually 
diminished Dot1 catalytic activity. We utilized the combination of two genetic tools to 
alter the levels of Dot1 activity: a) use of a dot1-G401A mutant (Fig. 1A), which 
produces a partially active protein [42], and b) expression of the gene under its own 
promoter, but from a single-copy plasmid (p[DOT1] or p[dot1-G401A]), which results 
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in reduced amount of protein (Fig. 2A). Given the distributive mode of action of Dot1 
[42], the wild-type strain expressing DOT1 from its endogenous locus displayed the 
maximal activity with the highest levels of H3K79-me3 and the lowest levels of 
H3K79-me1 (Fig. 2A). The catalytic activity was then gradually reduced, as manifested 
by decreasing levels of H3K79-me3 and increasing levels of H3K79-me1, following 
this sequence: DOT1 > p[DOT1] > dot1-G401A > p[dot1-G401A] > dot1-G401V ≈ 
dot1 2
led to a gradually elevated MMS resistance (Fig. 2B and 2D). In particular, 
quantification of the relative levels of each methylation state revealed a clear correlation 
between the drop of H3K79-me3 and the enhanced resistance to MMS (Fig. 2C and 
2D). Thus, tolerance to alkylating damage is finely modulated by H3K79 methylation 
levels. 
 
3.2. The MMS resistance of dot1 depends on PCNA ubiquitylation at lysine 164 
 Our previous observations indicated that the increased MMS resistance and 
mutagenesis frequency of dot1 is as a consequence of enhanced tolerance mediated by 
the TLS pathway of DNA damage bypass, because it is abolished in the absence of 
Pol/Rev1 [34]. DNA damage-induced PCNA ubiquitylation at lysine 164 is carried out 
by the Rad6/Rad18 (E2-E3) complex [7,11,47] and it is a key regulator of the tolerance 
to genotoxic insults (Fig. 3A; [12]). Therefore, to determine whether the MMS 
resistance conferred by the absence of Dot1-promoted H3K79 methylation relies on this 
PCNA modification, we deleted DOT1 in a PCNA ubiquitylation-deficient pol30-
K164R mutant [48]. As expected, the pol30-K164R mutant was extremely sensitive 
even to low MMS concentrations (Fig. 3B), underscoring the importance of DNA 
damage tolerance pathways in promoting viability after alkylating damage [11]. 
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However, although the absence of Dot1 suppresses the sensitivity of an ample range of 
mutants impaired in coping with MMS-induced lesions [34], deletion of DOT1 failed to 
suppress the MMS sensitivity of pol30-K164R (Fig. 3B). Moreover, the dot1 pol30-
K164R double mutant was more sensitive to MMS than pol30-K164R (Fig. 3B). 
Likewise, the rev3 dot1 or rev1 dot1 double mutants are also more sensitive to 
MMS than rev3 or rev1 [34]. These observations unveil the additional role of Dot1 in 
another process, such as homologous recombination [27], which becomes more relevant 
to deal with MMS damage in the absence of TLS. 
  
3.3. Threshold levels of Rad53 activity modulate DNA damage tolerance 
 Previous studies have shown that, like dot1, cells expressing an HA-tagged 
version of the Rad53 checkpoint kinase display increased MMS resistance and 
increased MMS-induced mutagenesis frequency ([40]; see also Fig. 5C). Moreover, 
recent observations indicate that the enhanced MMS resistance of rad53-HA also 
requires PCNA-K164 ubiquitylation (Fig. 3B) and TLS activity (AGS et al., submitted). 
 Thus, the similar phenotypes of dot1 and rad53-HA prompted us to further 
explore the possible relationship between Dot1 and Rad53 in the regulation of MMS 
resistance, as we have previously proposed [34]. Indeed, we found that the enhanced 
MMS resistance of dot1 was abolished in the absence of Rad53 because a rad53 
dot1 double mutant showed similar MMS sensitivity than rad53 (Fig. 4); therefore, 
MMS resistance conferred by dot1 requires Rad53 function. 
 Activation of Rad53 can be monitored by a well-characterized phosphorylation-
dependent electrophoretic mobility shift [49]. In the dot1 mutant, Rad53 is not fully 
activated in response to MMS ([32]; Fig. 5A, lanes 3 and 4). In contrast, in the rad53-
HA mutant, although the Rad53-HA protein can be activated to the same extent as the 
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wild-type protein, it is produced in much lower amounts and, consequently, also renders 
reduced levels of Rad53 activity ([40]; Figs. 5A and 5B). These observations suggest 
that the sub-optimal levels of Rad53 activity present in dot1 or rad53-HA cells lead to 
increased MMS resistance. Therefore, we generated a dot1 rad53-HA double mutant 
to analyze the extent of Rad53-HA phosphorylation (activation) and MMS resistance. 
Using anti-Rad53 antibodies, the Rad53-HA protein was not detectable in rad53-HA 
and dot1 rad53-HA cells in the absence of DNA damage (Fig. 5A, lanes 5 and 6). 
Interestingly, in the dot1 rad53-HA double mutant, in addition to the low amount of 
Rad53-HA protein characteristic of this tagged version, the levels of MMS-induced 
phosphorylated (and therefore active) Rad53-HA were further reduced compared with 
the rad53-HA single mutant (Fig. 5A, lanes 7 and 8). Indeed, the phosphorylated species 
of Rad53-HA induced by MMS were only barely detectable after long exposure of the 
membranes (Fig. 5A, middle panels). Using anti-HA antibodies, it was possible to 
detect a faint band corresponding to the basal form of Rad53-HA (Fig. 5B, lanes 1 and 
2), which was not detectable with anti-Rad53. In addition, upon MMS treatment, only 
the phosphorylated species of Rad53-HA were detected, and the reduced levels of 
activated Rad53-HA in the dot1 rad53-HA double mutant compared with the rad53-
HA single mutant were also manifested (Fig. 5B, lanes 3-6). Strinkingly, whereas both 
dot1 and rad53-HA single mutants display increased MMS resistance (Fig. 5C; see 
also Figs. 1, 2, 3 and 6; [34,40]), the dot1 rad53-HA double mutant was extremely 
sensitive to MMS (Fig. 5C), resembling a rad53 mutant (Fig. 4).  
 Moreover, if the increase in MMS resistance observed in dot1 results from the 
inability to fully activate Rad53, we reasoned that raising the levels of active Rad53 
kinase in the dot1 mutant by overproducing the protein should bring the MMS 
resistance closer to wild-type levels. Indeed, we found that moderate overexpression of 
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RAD53 from a high-copy plasmid significantly restored the levels of MMS-activated 
Rad53 in a dot1 mutant (Fig. 6A) and partially suppressed the increased MMS 
resistance of dot1 (Figs. 6B and 6C). Collectively, these results suggest that 
intermediate Rad53 activity (below wild-type levels) supports enhanced resistance to 
MMS, as occurs in dot1 or rad53-HA mutants. However, when Rad53 function drops 
below certain threshold level the cells become very sensitive to this genotoxic agent, 
which is the situation present in the dot1 rad53-HA double mutant and in rad53 (see 
Discussion). 
 
3.4. Dot1 and Rad53 modulate binding of Rev1 to Chromatin 
 Current models for TLS propose that when the replication machinery stalls at a 
lesion, binding of the Rev1 protein to monoubiquitylated PCNA serves as scaffold for 
recruiting the Pol polymerase to the stalled fork by virtue of the interaction between 
Rev1 and the Rev7 accessory subunit of Pol [50-52]. This would promote the switch of 
the replicative polymerase by the TLS polymerase to continue replication past the lesion 
[53-55]. However, compelling evidence supports that DNA damage tolerance 
mechanisms function during the G2/M phase acting on gaps behind replication forks 
[56-59]. In any case, Rev1 is a key regulator of Pol activity [10], and it has been 
shown that forms chromosomal foci [60,61]; therefore, we examined MMS-induced 
Rev1 localization in nuclear spreads of wild-type, dot1 and rad53-HA strains. 
 Chromatin-associated Rev1 signal was observed both in untreated and MMS-
treated cells (Fig. 7A). To analyze in more detail the binding of Rev1 to chromosomes, 
we quantified the number of Rev1 foci detected in the nuclear spreads and established 
three categories (Fig. 7B). In the absence of damage, all strains analyzed contained a 
high number of Rev1 foci on chromosomes; most nuclei corresponded to class III (i.e., 
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more than 30 foci per nucleus). However, after MMS treatment, the number of Rev1 
foci remarkably diminished in chromosome spreads from the wild-type strain, but 
remained high in the dot1 and rad53-HA mutants (Fig. 7). Indeed, whereas most 
nuclei from the MMS-treated dot1 and rad53-HA mutants contained more than 30 
Rev1 foci (79% and 61% of nuclei belonged to class III, respectively), only 34% of 
wild-type nuclei fell into this category (Fig. 7B). Representative images of the most 
abundant class of nuclei for each condition are shown in Fig. 7A. 
 In summary, these results suggest that full activation of Rad53 promotes Rev1 
disassembly from chromosomes upon MMS treatment, but the reduced Rad53 activity 
present in dot1 and rad53-HA allows extended Rev1 binding to chromatin accounting 
for the increased MMS resistance of these mutants.  
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4. Discussion 
 We have previously described a role for the histone H3K79 methyltransferase 
Dot1 in the tolerance to alkylating DNA damage [34]. Here, we have further 
characterized this function of Dot1 by first analyzing the impact of different 
methylation states of H3K79 in the response to continuous MMS exposure. We provide 
evidence indicating that the regulation of DNA damage tolerance by Dot1 depends on 
its catalytic activity on H3K79 and not on other possible unknown substrate(s) because, 
like dot1 both a catalytically-defective dot1-G401V allele, and a non-methylatable 
H3-K79A version of histone H3 confer MMS hyper-resistance. To investigate how 
different degrees of H3K79 methylation affect MMS resistance, we have engineered 
and analyzed a set of strains with progressively crippled Dot1 activity, ranging between 
wild-type DOT1 and dot1 as the maximal and minimal Dot1 catalytic activity, 
respectively. We find a striking correlation between the decline of Dot1 activity and the 
increase in MMS resistance. This correlation was particularly evident for the loss of 
H3K79-me3, suggesting that this methylation state is the most relevant for the MMS 
response. Similarly, different functional relevance for the different methylation states of 
H3K79 in the coordination of DNA repair and checkpoint activation in response to UV 
has been proposed [62]. In contrast, it has been clearly demonstrated that chromatin 
silencing relies on global levels of H3K79 methylation, and not on specific methylation 
states [42]. Importantly, the MMS resistance conferred by the absence of Dot1 is 
independent of the silencing SIR complex [34]. 
 The role of Dot1 in multiple nuclear processes, such as transcriptional silencing, 
meiotic checkpoint, DNA damage checkpoint or DSB repair, relies on the regulated 
binding of various key factors to specific chromosomal regions [25-27,33]. In principle, 
the impact of Dot1 (i.e. H3K79 methylation) in MMS resistance and the higher number 
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of MMS-induced chromosome-associated Rev1 foci in the dot1 mutant could emanate 
from a direct effect of a peculiar chromatin structure dictated by the H3K79 methylation 
status modulating the recruitment of the TLS machinery. However, our results support 
an alternative possibility implying that the effect of Dot1 in DNA damage tolerance is 
exerted indirectly through the regulation of the Rad53 checkpoint kinase. The fact that a 
rad53-HA mutant, characterized by reduced levels of the kinase, substantially 
phenocopies dot1 in the response to chronic MMS exposure ([34,40]; this work) 
suggested a possible relationship between Dot1 and Rad53 in the regulation of tolerance 
to alkylating damage. Supporting this possibility, we find that the MMS resistance of 
both dot1 and rad53-HA depends on ubiquitylation of PCNA at K164, which is a 
crucial regulator of the TLS mechanism of DNA damage tolerance. Moreover, we show 
here that the increased MMS resistance of the dot1 mutant depends on Rad53. 
 Both dot1 and rad53-HA mutants display enhanced resistance to alkylating 
damage and increased TLS-dependent MMS-induced mutagenesis. Strinkingly, in both 
mutants, the levels of Rad53 activated by MMS treatment are reduced compared to the 
wild type, but for different reasons. In the case of dot1, Rad53 is produced at normal 
levels (see Fig. 5A, lanes 1 and 2 and Fig. 6A, lanes 5 and 7), but the inability to 
properly recruit the Rad9 adaptor to DNA damage sites results in defective activation of 
Rad53 ([27,32,33]; Fig. 5). On the other hand, the rad53-HA allele gives rise to a 
functional protein, which can be fully activated; however, it is highly unstable, resulting 
in the production of low levels of MMS-induced active kinase ([40]; see also Fig. 5A, 
lane 7). In the dot1 rad53-HA double mutant, the activation of the low amounts of 
kinase produced by the HA-tagged allele is further hampered by the absence of DOT1 
resulting in barely detectable levels of phosphorylated kinase. Remarkably, whereas the 
dot1 and rad53-HA single mutants show increased MMS resistance, the dot1 rad53-
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HA double mutant shows strong MMS sensitivity implying that threshold levels of 
Rad53 activity determine the outcome of the cellular response to alkylating damage. We 
favor the scenario presented in Fig. 8 to explain our findings. In the face of MMS 
challenge that prevents the advance of replication forks, the wild-type strain fully 
activates Rad53 and the subsequent checkpoint responses controlled by this effector 
kinase, including cell cycle arrest, stabilization of replication forks and induction of 
DNA repair mechanisms [5]. In addition, high levels of Rad53 activity would 
negatively regulate the TLS mechanism of damage tolerance to prevent excessive 
mutagenesis. We propose that the sub-optimal levels of activated Rad53 present in 
rad53-HA mutants or in mutants that cripple H3K79 methylation (dot1-G401A, dot1-
G401V, dot1), while still preventing replication fork collapse, allow cell cycle 
progression and TLS-dependent replication across damage. Consistent with this idea, 
analysis of MMS-treated cells lacking the Rad53 phosphatases Pph3 an Ptc2 suggested 
that a graded response to the level of Rad53 phosphorylation occurs controlling 
replication fork restart [63,64]. These authors propose that a cycle of Rad53 activation 
and deactivation coordinates DNA repair with TLS-dependent replication fork 
progression through damaged DNA by a mechanism involving the Cdc7-Dbf4 kinase 
activity [64]. Indeed, the cooperation of a functional Rad53-dependent checkpoint 
response with multiple pathways involving base excision repair, recombination and 
DNA damage tolerance has been shown to be crucial for a proper cellular response to 
alkylated DNA [65,66]. Our analysis of the dot1 rad53-HA double mutant suggests 
that when Rad53 activity drops below a critical threshold level, damaged replication 
forks would irreversibly collapse, like in rad53 [67,68], resulting in cell death and 
pronounced MMS sensitivity (Fig. 8). We note, however, that in contrast with rad53, 
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the low amounts of the Rad53-HA protein in the dot1 rad53-HA mutant must be 
sufficient to support viability in undamaged cells.  
 The Rev1 protein is a crucial regulator of TLS activity because of its structural 
function [10]; therefore, we focused on Rev1 to investigate how Dot1/Rad53 function 
impinges on TLS-dependent mutagenic bypass of MMS-induced lesions. In particular, 
we examined Rev1 localization to chromatin by immunofluorescence of nuclear 
spreads. We found that Rev1 foci are present in most nuclei even in the absence of 
MMS damage, suggesting that there is a constitutive localization of Rev1 to 
chromosomes. Similar results have been reported for 4NQO-treated cells [61]. Since 
PCNA ubiquitylation is triggered by DNA damage [11], these observations imply that 
the basal formation of Rev1 foci does not depend on the interaction with ubiquitylated 
PCNA. Consistent with this possibility, we detect Rev1 foci in the ubiquitylation-
deficient pol30-K164R mutant (Supplementary Figure 1). In fact, studies of mouse and 
yeast Rev1 suggest that the BRCT domain of Rev1 is required for its constitutive 
recruitment to foci, whereas the ubiquitin-binding motifs specifically drive Rev1 to 
damaged replication forks [60,69,70]. Moreover, in DT40 chicken cells, Rev1 maintains 
progression of replication forks upon DNA damage independently of PCNA 
ubiquitylation [71].  
 Strikingly, although most nuclei maintain Rev1 signal, we observe a decrease in 
the number of Rev1 foci per nucleus in MMS-treated wild-type cells. Since mutagenic 
TLS is induced by alkylating damage [34], this reduced number of Rev1 foci (or a 
significant fraction of them) must by actively engaged in TLS. In contrast, the number 
of chromatin-bound Rev1 foci remains elevated in the dot1 or rad53-HA mutants, 
providing the opportunity for more TLS-dependent mutagenic events once DNA 
damage-induced ubiquitylation of PCNA occurs. We propose that full activation of the 
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Rad53 checkpoint kinase, which depends on Dot1, somehow restrains TLS activity by 
preventing promiscuous formation of Rev1 foci associated with chromosomes. Rev1 
undergoes Mec1-dependent phosphorylation, which promotes Polactivity only in 
NER-deficient cells [61,72]. Phosphorylation of Rev1 also requires the checkpoint 
clamp ‘9-1-1’ and the clamp loader Rad24; however, it is independent of Rad53 [72]. 
Therefore, it is unlikely that this posttranslational modification of Rev1 controls the 
formation of TLS-active Rev1 foci. Perhaps, Rad53 acts on other regulators of TLS that 
mediate Rev1 chromosomal binding or stability. Future studies will be aimed to unveil 
these mechanisms. 
 In summary, our studies provide insight into how a chromatin modification, 
namely Dot1-dependent H3K79 methylation, regulates the tolerance to alkylating 
damage by TLS through modulation of Rad53 activity. TLS constitutes one important 
aspect of the coordinated global cellular response to DNA damage because of the ability 
to bypass lesions that impede replication progression, thus preventing fork collapse and 
eventual formation of DNA breaks potentially leading to chromosomal rearrangements. 
However, given the error-prone nature of TLS, this process must be kept under strict 
control to avoid excessive mutagenesis, which can also have deleterious consequences. 
Therefore, an appropriate balance between error-prone and error-free processes to face 
DNA damage is essential to avoid genomic instability, which is directly linked to cancer 
development. Our studies in yeast reveal that the conserved Rad53 checkpoint kinase 
contributes to finely tune this balance at least by regulating the levels of chromatin-
bound Rev1. Recent studies using a mouse model point to the influence of correct Rev1 
levels in reducing the incidence of carcinogen-induced lung cancer [73], highlighting 
the importance of these mechanisms for the maintenance of genomic stability. 
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FIGURE LEGENDS 
 
Fig. 1 - The regulation of MMS resistance by Dot1 relies on its H3K79 
methyltransferase activity. (A) Schematic representation of the Dot1 protein with the 
glycine at position 401 in the catalytic domain that has been mutated to valine or alanine 
in the dot1 alleles generated, as indicated. (B) Western blot analysis of H3K79 mono-, 
di- and tri-methylation in wild type (BY4742), dot1 (NKI3002) and dot1-G401V 
(NKI3018) strains. Ponceau S staining is shown as a loading control. (C) Five-fold 
serial dilutions of exponentially growing cells from the strains used in (B) were spotted 
onto YPDA and 0.025% MMS plates and incubated for 72 hours. (D) Five-fold serial 
dilutions of exponentially growing wild-type (YAF120), H3-K79A (YAF124) and 
dot1 (YP1332) cells were spotted onto YPDA and 0.015% MMS plates and incubated 
for the indicated time. 
 
Fig. 2 - The status of H3K79 methylation modulates tolerance to MMS. (A) 
Western blot analysis of strains producing the different versions of Dot1 either from the 
endogenous loci (DOT1, dot1-G401A and dot1-G401V) or from a single-copy plasmid 
(p[DOT1] and p[dot1-G401A]), as indicated. The dot1 mutant was also included. Note 
that the two isoforms of Dot1 detected correspond to two alternative translational start 
sites [74]. Exponentially growing cells on SC-Leu were treated with 0.02% MMS for 2 
hours. Cell extracts were analyzed with anti-Dot1 antibodies and with antibodies that 
specifically recognize the mono-, di- and tri-methylated forms of H3K79 or the total 
histone H3, as indicated. Strains are: YP712+pRS315 (DOT1), YP1175+pRS315-DOT1 
(p[DOT1]), YP1185+pRS315 (dot1-G401A), YP1175+pFvL54 (p[dot1-G401A]), 
YP1181+pRS315 (dot1-G401V) and YP1175+pRS315 (dot1). (B) Five-fold serial 
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dilutions of cultures from the same strains analyzed in (A) were spotted onto YPDA and 
0.015% MMS plates incubated for the indicated time. (C) Quantification of the relative 
levels of H3K79 mono-, di- and tri-methylation from the same strains used in (A). The 
maximum value of each methylation state resulting from the average of three 
experiments was considered 100%. (D) Quantification of the MMS resistance. Colonies 
were counted after 40 h of incubation on YPDA and 0.015% MMS plates. Average and 
standard deviation from three independent counts are presented. 
 
Fig. 3 - The MMS resistance of dot1 and rad53-HA depends on PCNA-K164 
ubiquitylation (A) Schematic diagram of the PCNA sliding clamp with the relevant 
MMS-induced ubiquitylation event. (B) Five-fold serial dilutions of exponentially 
growing cells were spotted onto YPDA and 0.0005% MMS plates. Note that the strong 
MMS sensitivity of the pol30-K164R mutant requires the use of a very low MMS 
concentration, at which dot1 and rad53-HA single mutants do not show increased 
resistance. Strains are YP813 (wild type), YP1215 (dot1), YP814 (rad53-HA), 
YP1553 (pol30-K164R), YP1217 (dot1 pol30-K164R) and YP1554 (rad53-HA pol30-
K164R).  
 
Fig. 4 - The MMS resistance conferred by dot1 requires Rad53. Five-fold serial 
dilutions of exponentially growing cells were spotted onto YPDA, 0.00375% MMS, 
0.005% MMS and 0.01% MMS plates incubated for the indicated time. Strains are 
U952-3B (wild type), YP558 (dot1), U960-5C (rad53) and YP755 (dot1 rad53). 
Note that all strains are in an sml1 background to maintain rad53 viability. 
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Fig. 5 - Analysis of Rad53 activation and MMS resistance in dot1 rad53-HA. (A) 
Western blot analysis with anti-Rad53 antibodies of wild-type, dot1, rad53-HA and 
rad53-HA dot1 exponentially growing cells either untreated or treated with 0.03% 
MMS for 1 h, as indicated. Double arrows mark the phosphorylated (activated) species 
of Rad53 (or Rad53-HA). The middle panels show an overexposure of the film to 
visualize the low levels of phosphorylated Rad53-HA in the absence of Dot1. Ponceau 
S staining was used as a loading control. (B) Western blot analysis with anti-HA 
antibodies of rad53-HA and rad53-HA dot1 exponentially growing cells either 
untreated or treated with 0.03% MMS for 1 h or 2 h, as indicated. The wild-type strain 
was included as an untagged control. Double arrows mark the phosphorylated 
(activated) species of Rad53-HA. The middle panel represents a computer-enhanced 
display of the upper blot to make more perceptible the basal form of Rad53-HA 
detected only in untreated cells (single arrow). Ponceau S staining was used as a loading 
control. (C) Five-fold serial dilutions of exponentially growing cells were spotted onto 
YPDA, 0.015% MMS and 0.02% MMS plates incubated for the indicated time. Strains 
are YP813 (wild type), YP1215 (dot1), YP814 (rad53-HA) and YP1216 (rad53-HA 
dot1). 
 
Fig. 6 - Overexpression of RAD53 partially suppresses the increased MMS 
resistance of dot1. (A) Western blot analysis of Rad53 in wild-type (YP813) and 
dot1 strains (YP1215) transformed with vector alone (pRS426; lanes 5-8) or with a 
high-copy plasmid expressing RAD53 (pSS145; lanes 1-4) either untreated or treated 
with 0.03% MMS for 1.5 h, as indicated. Double arrows mark the phosphorylated 
species of Rad53. Ponceau S was used as a loading control. (B) 2.5-fold serial dilutions 
of cells grown on SC-Ura to log phase were spotted onto YPDA and 0.025% MMS 
37 
plates incubated for the indicated time. Strains are YP813+pRS426 (wild type), 
YP1215+pRS426 (dot1) and YP1215+pSS145 (2-RAD53 dot1). (D) Quantification 
of the MMS resistance. Colonies were counted after 48 h of incubation on YPDA and 
0.025% MMS plates. Average and standard deviation from six independent counts are 
presented. The p value of the statistical comparison is also shown. 
 
 
Fig. 7 - The dot1 and rad53-HA mutants display increased number of 
chromosome-associated Rev1 foci upon MMS treatment. (A) Spread nuclei of wild-
type (YP1471), dot1 (YP1458) and rad53-HA (YP1460) strains carrying REV1 tagged 
with the myc epitope, as well as the untagged control strain (YP813), were stained with 
DAPI (blue) and anti-myc antibodies (red). Cells were untreated (upper panels) or 
treated with 0.03% MMS for 1 h (lower panels). Representative nuclei of the indicated 
categories (see below) are presented. (B) Quantification of the number of Rev1 foci in 
spread nuclei of the strains analyzed in (A) either untreated (left graph) or treated with 
MMS (right graph). The nuclei were classified in three categories according to the 
number of chromatin-bound Rev1 foci, as indicated. The percentage of nuclei belonging 
to each category is represented. The number of nuclei analyzed for each strain is 
indicated (n). 
 
Fig. 8 - Threshold levels of Rad53 activity modulate the tolerance to alkylating 
DNA damage. See discussion for details. 
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Table 1. Saccharomyces cerevisiae strains  
Strain Genotype Source/Reference 
BR1919a MATa leu2-3,112 his4-260 ura3-1 ade2-1 thr1-4 trp1-289 [75] 
YP712 BR1919a lys2NheI zip1::LYS2 This study 
YP1175 BR1919a lys2NheI zip1::LYS2 dot1::kanMX6 This study 
YP1181 BR1919a lys2NheI zip1::LYS2 dot1::kanMX6::dot1-
G401V::URA3 
This study 
YP1185 BR1919a lys2NheI zip1::LYS2 dot1::kanMX6::dot1-
G401A::URA3 
This study 
W303-1A MATa leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 can1-100 
rad5-G535R 
R. Rothstein 
W303-1B MAT leu2-3,112 trp1-1 ura3-1 ade2-1 his3-11,15 can1-100 
rad5-G535R 
R. Rothstein 
YAF120 W303-1A hhf2-hht2::natMX hta1-htb1::hphMX4 hht1-
hhf1::kanMX hta2-htb2::natMX GAL1::YLR454w::TRP1 
<pRS315-HTA1-Flag-HTB1, HHT1-HHF1> 
[46] 
YAF124 W303-1A hhf2-hht2::natMX hta1-htb1::hphMX4 hht1-
hhf1::kanMX hta2-htb2::natMX GAL1::YLR454w::TRP1 
<pRS315-HTA1-Flag-HTB1, hht1-K79A-HHF1> 
[46] 
YP1332 YAF120 dot1::URA3 This study 
YP813a W303-1A RAD5 bar1::LEU2 [51] 
YP814 W303-1A RAD5 bar1::LEU2 rad53-3HA::TRP1 This study 
YP1215 W303-1A RAD5 bar1::LEU2 dot1:kanMX6 This study 
YP1216 W303-1A RAD5 bar1::LEU2 dot1:kanMX6 rad53-3HA::TRP1 This study 
TH291 W303-1A RAD5 pol30-K164R [48] 
YP1553 W303-1B RAD5 bar1::URA3 pol30-K164R  This study 
YP1554 W303-1A RAD5 bar1::URA3 pol30-K164R rad53-3HA::TRP1  This study 
YP1217 W303-1B RAD5 bar1::URA3 pol30-K164R dot1::kanMX6 This study 
U952-3B W303-1A RAD5 sml1::HIS3 [76] 
YP558 W303-1A RAD5 sml1::HIS3 dot1::URA3 This study 
U960-5C W303-1A RAD5 sml1-1 rad53::HIS3 [76] 
YP755 W303-1A RAD5 rad53::HIS3 sml1-1 dot1::kanMX6 This study 
Table 1
2 
YP1471 W303-1A RAD5 bar1::LEU2 REV1::13myc::HISMX6 This study 
YP1458 W303-1A RAD5 bar1::LEU2 REV1::13myc::HISMX6 
dot1::kanMX6 
This study 
YP1460 W303-1A RAD5 bar1::LEU2 REV1::13myc::HISMX6 rad53-
3HA::TRP1 
This study 
YP1531 W303-1A RAD5 bar1::LEU2 REV1::13myc::HISMX6 pol30-
K164R 
This study 
BY4742 MAT his31 leu20 ura30 lys20   [77] 
NKI3002  BY4742 dot1::natMX4 [42] 
NKI3018 BY4742 dot1::dot1-G401V F. van Leeuwen 
 
aCorresponds to strain YLW70 [51]. 
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Table 2. Plasmids  
Plasmid Description Source/Reference 
pRS315 CEN LEU2 [78] 
pRS315-DOT1 CEN LEU2 DOT1 [42] 
pFvL54 CEN LEU2 dot1-G401A [42] 
pRS306 URA3 [78] 
pFF003 URA3 dot1-G401A F. van Leeuwen 
pTW043 URA3 dot1-G401V F. van Leeuwen 
pRS426 2 URA3 [79] 
pSS145 2 URA3 RAD53 This study 
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